Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
Treatment with interferon beta-1a plus the antiviral remdesivir was not superior to remdesivir alone.
Many people who received any of the authorized COVID-19 vaccines will be eligible for an additional dose.
Co-occurring health disorders appear to contribute to increased risk, NIH study suggests.
People who received the Moderna COVID-19 vaccine had strong immune memory of SARS-CoV-2 six months after vaccination.
Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.
Third dose OK’d for people over 65, those at risk for severe COVID-19 and those at high risk of exposure to the coronavirus.
About half of people hospitalized with COVID-19 had antibodies that could mistakenly attack the body’s own proteins and tissues.
The committee voted against third shot for all adults, however, casting doubts on Biden’s booster plan.
Antibodies that mistakenly target the body’s own immune-system proteins may account for about 20% of COVID-19 deaths.
Community clinics in low-income communities saw a decline in breast cancer screening during the pandemic, new report finds.
Certain types of cancer treatment can lead to inadequate immune response.
Coronavirus transmission via fomites is markedly less efficient than airborne transmission but does occur.
The experimental vaccines use the same technology as the highly effective Moderna COVID-19 shot.
Full approval could encourage more people to get vaccinated and raises the prospect of off-label use.
Health officials are preparing to offer booster shots for all adults starting eight months after the second dose.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.